Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 39
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Schoeler, Tabea Monk, Anna Sami, Musa B Klamerus, Ewa Foglia, Enrico Brown, Ruth Camuri, Giulia Altamura, A Carlo Murray, Robin and Bhattacharyya, Sagnik 2016. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. The Lancet Psychiatry, Vol. 3, Issue. 3, p. 215.


    Barrowclough, C. Gregg, L. Lobban, F. Bucci, S. and Emsley, R. 2015. The Impact of Cannabis Use on Clinical Outcomes in Recent Onset Psychosis. Schizophrenia Bulletin, Vol. 41, Issue. 2, p. 382.


    Degenhardt, Louisa Coffey, Carolyn Hearps, Stephen Kinner, Stuart A. Borschmann, Rohan Moran, Paul and Patton, George 2015. Associations between psychotic symptoms and substance use in young offenders. Drug and Alcohol Review, Vol. 34, Issue. 6, p. 673.


    Kerner, Berit 2015. Comorbid substance use disorders in schizophrenia: A latent class approach. Psychiatry Research, Vol. 225, Issue. 3, p. 395.


    Sarrazin, Samuel Louppe, Florence Doukhan, Raphael and Schürhoff, Franck 2015. A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches. Annals of General Psychiatry, Vol. 14, Issue. 1,


    van der Meer, F. J. and Velthorst, E. 2015. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study. Psychological Medicine, Vol. 45, Issue. 09, p. 1977.


    Wagner, Daniel Koester, Philip Becker, Benjamin Gouzoulis-Mayfrank, Euphrosyne Hellmich, Martin and Daumann, Joerg 2015. A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users. Psychopharmacology, Vol. 232, Issue. 5, p. 897.


    Kalant, Harold 2014. The Effects of Drug Abuse on the Human Nervous System.


    Løberg, Else-Marie Helle, Siri Nygård, Merethe Berle, Jan Øystein Kroken, Rune A. and Johnsen, Erik 2014. The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. Frontiers in Psychiatry, Vol. 5,


    Renard, Justine Krebs, Marie-Odile Le Pen, Gwenaëlle and Jay, Thérèse M. 2014. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Frontiers in Neuroscience, Vol. 8,


    Barrowclough, C. Emsley, R. Eisner, E. Beardmore, R. and Wykes, T. 2013. Does Change in Cannabis Use in Established Psychosis Affect Clinical Outcome?. Schizophrenia Bulletin, Vol. 39, Issue. 2, p. 339.


    Batalla, Albert Garcia-Rizo, Clemente Castellví, Pere Fernandez-Egea, Emili Yücel, Murat Parellada, Eduard Kirkpatrick, Brian Martin-Santos, Rocío and Bernardo, Miguel 2013. Screening for substance use disorders in first-episode psychosis: Implications for readmission. Schizophrenia Research, Vol. 146, Issue. 1-3, p. 125.


    Fischer, Benedikt Dawe, Meghan McGuire, Fraser Shuper, Paul A. Capler, Rielle Bilsker, Dan Jones, Wayne Taylor, Benjamin Rudzinski, Katherine and Rehm, Jürgen 2013. Feasibility and impact of brief interventions for frequent cannabis users in Canada. Journal of Substance Abuse Treatment, Vol. 44, Issue. 1, p. 132.


    Hall, Wayne and Degenhardt, Louisa 2013. Principles of Addiction.


    Papachristou, Efstathios Frangou, Sophia and Reichenberg, Abraham 2013. Expanding conceptual frameworks: Life course risk modelling for mental disorders. Psychiatry Research, Vol. 206, Issue. 2-3, p. 140.


    Spano, Maria Sabrina Fattore, Liana Cadeddu, Francesca Fratta, Walter and Fadda, Paola 2013. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology, Vol. 225, Issue. 3, p. 531.


    Baker, A. L. Hiles, S. A. Thornton, L. K. Hides, L. and Lubman, D. I. 2012. A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatrica Scandinavica, Vol. 126, Issue. 4, p. 243.


    Baldacchino, Alexander Hughes, Zoe Kehoe, Michael Blair, Hannah Teh, Ying Windeatt, Stacey and Crome, Ilana B. 2012. Cannabis Psychosis: Examining the Evidence for a Distinctive Psychopathology in a Systematic and Narrative Review. The American Journal on Addictions, Vol. 21, p. S88.


    Baldacchino, Alex Blair, Hannah Sommer, Borge Tan, Liz Riglietta, Marco Tidone, Laura Scherbaum, Norbert Grosse-Vehne, Eva Little, Hilary Galea, Sue and Crome, Ilana 2012. Clinical outcomes for psychotic and co-morbid patients admitted to acute psychiatric wards in four European centres – follow-up to 6 months. Mental Health and Substance Use, Vol. 5, Issue. 3, p. 240.


    Gleason, K A Birnbaum, S G Shukla, A and Ghose, S 2012. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Translational Psychiatry, Vol. 2, Issue. 11, p. e199.


    ×

The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study

  • LOUISA DEGENHARDT (a1), CHRIS TENNANT (a2), STUART GILMOUR (a1), DAVID SCHOFIELD (a2), LOUISE NASH (a2), WAYNE HALL (a3) and DIANA McKAY (a4)
  • DOI: http://dx.doi.org/10.1017/S0033291707009956
  • Published online: 01 February 2007
Abstract

Background. The aim was to examine the temporal relationships over 10 months between cannabis use and symptoms of psychosis and depression in people with schizophrenia and related disorders. The design was a prospective study of 101 patients with schizophrenia and related disorders who were assessed monthly over 10 months on medication compliance, cannabis and other drug use, symptoms of depression and symptoms of psychosis.

Method. Linear regression methods to assess relationships between cannabis use and symptoms of psychosis and depression while adjusting for serial dependence, medication compliance and other demographic and clinical variables.

Results. Cannabis use predicted a small but statistically significant increase in symptoms of psychosis, but not depression, after controlling for other differences between cannabis users and non-users. Symptoms of depression and psychosis did not predict cannabis use.

Conclusion. Continued cannabis use by persons with schizophrenia predicts a small increase in psychotic symptom severity but not vice versa.

Copyright
Corresponding author
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia. (Email: l.degenhardt@unsw.edu.au)
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×